Nuvation Bio (NUVB) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to 0.54.
- Nuvation Bio's Equity Ratio fell 3840.63% to 0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54, marking a year-over-year decrease of 3840.63%. This contributed to the annual value of 0.86 for FY2024, which is 1189.32% down from last year.
- Latest data reveals that Nuvation Bio reported Equity Ratio of 0.54 as of Q3 2025, which was down 3840.63% from 0.58 recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Equity Ratio ranged from a high of 0.98 in Q1 2023 and a low of 0.43 during Q2 2024
- Its 3-year average for Equity Ratio is 0.82, with a median of 0.88 in 2024.
- Per our database at Business Quant, Nuvation Bio's Equity Ratio plummeted by 5559.8% in 2024 and then soared by 3324.6% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Equity Ratio stood at 0.97 in 2023, then fell by 11.89% to 0.86 in 2024, then plummeted by 36.85% to 0.54 in 2025.
- Its Equity Ratio was 0.54 in Q3 2025, compared to 0.58 in Q2 2025 and 0.85 in Q1 2025.